GHK-Cu (Copper Peptide) Research Overview: Skin, Tissue Repair, and Anti-Aging
Research Use Only. This article is for scientific and educational reference only. All products are sold for research purposes and are not intended for human or animal consumption.
Overview
GHK-Cu (glycyl-L-histidyl-L-lysine:copper 2+) is a naturally occurring tripeptide that binds copper ions with high affinity. It was first isolated from human plasma by Loren Pickart in 1973. GHK-Cu is found naturally in human plasma, saliva, and urine, and its plasma concentration declines significantly with age — from approximately 200 ng/mL at age 20 to 80 ng/mL at age 60.
Mechanism of Action
GHK-Cu's biological activity is remarkably broad for a simple tripeptide:
Collagen synthesis: GHK-Cu stimulates the production of collagen types I, III, and IV, as well as elastin and glycosaminoglycans (hyaluronic acid, dermatan sulfate). This makes it a key research tool in skin aging and wound healing biology.
Gene expression regulation: Microarray studies have shown that GHK-Cu modulates the expression of over 4,000 human genes, including upregulation of genes involved in tissue repair, anti-oxidation, and anti-inflammation, and downregulation of genes associated with inflammation, cancer progression, and neurodegeneration.
Antioxidant activity: GHK-Cu scavenges free radicals and upregulates antioxidant enzymes including superoxide dismutase and catalase.
Anti-inflammatory: GHK-Cu inhibits the release of inflammatory cytokines including TNF-α and IL-6.
Wound healing: GHK-Cu activates fibroblasts, keratinocytes, and endothelial cells, accelerating all phases of wound healing.
Skin Research
Collagen and elastin: Clinical studies have demonstrated that topical GHK-Cu formulations increase skin collagen density, improve skin elasticity, and reduce fine lines and wrinkles.
Wound healing: GHK-Cu has been shown to accelerate wound closure in both in vitro and in vivo models. It promotes re-epithelialization, granulation tissue formation, and angiogenesis.
Photoaging: Research has shown that GHK-Cu reverses some markers of UV-induced skin aging, including reduced collagen expression and increased matrix metalloproteinase activity.
Systemic Research
Lung tissue repair: Research has shown that GHK-Cu reduces fibrosis and promotes repair in lung tissue models, with potential relevance to COPD and pulmonary fibrosis research.
Neurological research: GHK-Cu has been shown to upregulate BDNF and other neurotrophic factors, and to reduce the expression of genes associated with Alzheimer's disease pathology in gene expression studies.
Anti-cancer research: GHK-Cu has demonstrated anti-metastatic effects in cancer cell line studies, reducing the expression of genes involved in tumor invasion and metastasis.
Comparison with Other Skin/Repair Peptides
| Parameter | GHK-Cu | BPC-157 | TB-500 | |-----------|--------|---------|--------| | Collagen synthesis | Strong | Moderate | Moderate | | Wound healing | Strong | Strong | Strong | | Angiogenesis | Moderate | Strong | Strong | | Gene regulation | Broad (4,000+ genes) | Limited data | Limited data | | Topical efficacy | Excellent | Limited data | Limited data | | Anti-aging | Strong evidence | Limited data | Limited data |
Summary
GHK-Cu is one of the most extensively studied peptides in skin biology and wound healing research. Its ability to modulate thousands of genes, stimulate collagen synthesis, and accelerate wound healing makes it a uniquely versatile research tool. The age-related decline in plasma GHK-Cu levels provides a compelling rationale for its study in aging biology.
See Also: BPC-157: The Complete Research Guide | TB-500 + BPC-157 Combination Research
Was this article helpful?
Click a star to rate